Jiazheng Cao

机构：Jiangmen Central Hospital

发表论文 48 篇 · 总被引 761 次 · h-index 15

代表论文

• m6A-immune-related lncRNA prognostic signature for predicting immune landscape and prognosis of bladder cancer (2022 · Journal of Translational Medicine · 被引 71)
• circCHST15 is a novel prognostic biomarker that promotes clear cell renal cell carcinoma cell proliferation and metastasis through the miR-125a-5p/EIF4EBP1 axis (2021 · Molecular Cancer · 被引 69)
• Multimodal recurrence scoring system for prediction of clear cell renal cell carcinoma outcome: a discovery and validation study (2023 · The Lancet Digital Health · 被引 48)
• Fatty acids metabolism affects the therapeutic effect of anti-PD-1/PD-L1 in tumor immune microenvironment in clear cell renal cell carcinoma (2023 · Journal of Translational Medicine · 被引 42)
• LRP1 induces anti-PD-1 resistance by modulating the DLL4-NOTCH2-CCL2 axis and redirecting M2-like macrophage polarisation in bladder cancer (2024 · Cancer Letters · 被引 32)
• Hsa_circ_0057105 modulates a balance of epithelial‐mesenchymal transition and ferroptosis vulnerability in renal cell carcinoma (2023 · Clinical and Translational Medicine · 被引 24)